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ABSTRACT  
 
 
This thesis consists of five parts. In the first part, an automated method for quantitative 
analysis of phospholipid compositions of cells and tissues by liquid chromatography-
mass spectrometry was developed. In the second part, this method was applied to 
investigate brain lipid compositions of patients with progressive epilepsy with mental 
retardation (EPMR), caused by mutations in the CLN8 gene. We were able to show 
major progressive alterations in brain lipid profiles of EPMR patients which may 
contribute to disease pathogenesis in those patients. In the third part, a novel approach 
to investigate the metabolism of single glycerophospholipid molecular species in living 
cells was developed. This approach was applied to study mechanisms of acyl chain 
remodeling, i.e. the exchange of fatty acyl residues, of aminophospholipids in BHK and 
HeLa cells. In the fourth part a novel mass-spectrometric approach was developed to 
investigate the substrate specificity of phospholipases and was utilized to elucidate the 
specificities of secretory A-type phospholipases in unprecedented detail. We showed 
that the specificity of those phospholipases depended mainly on the propensity of the 
substrates to efflux from the membrane and interactions between the substrate and the 
enzyme catalytic site are secondary. In the fifth part of this thesis, mechanisms of 
mammalian glycerophospholipid homeostasis were reviewed and novel theoretical 
considerations presented. 
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1. INTRODUCTION 
 
Glycerophospholipids (GPLs) form the essential lipid bilayer of all biological membranes and are 
also intimately involved in signal transduction, regulation of membrane trafficking and many 
other membrane-related phenomena [1, 2]. GPLs are composed of a glycerol backbone with a 
polar head group attached to the sn3-position via a phosphate and hydrocarbon chains linked 
to the sn1 and sn2 hydroxyl groups (cf. Figure  1). GPLs can be divided into several classes 
(defined by the structure of the polar head group) the major ones being the 
phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylinositols (PI), 
phosphatidylserines (PS) and cardiolipins (CL) [3]. Each GPL class consists of numerous 
molecular species i.e. molecules which have the same head group but differ in respect of the 
hydrocarbon (alkyl) moieties. The alkyl chain at the sn2 position is always ester-linked to the 
glycerol moiety, but the one in the sn1 position can be linked via an ester, ether or a vinylether 
bond. Typical length of the chain varies from 14 to 24 carbons and the number of double bonds 
from 0 to 6. The positions and configurations of the double bonds vary considerably. The alkyl 
chain in the sn1 position is typically saturated or monounsaturated, while that in the sn2 
position is often polyunsaturated. 
 
 
 
  
 
 
 
 
 
 
 
 
 
FIGURE 1. General structure of glycerophospholipids.  
 
Because of the large number of different alkyl chain combinations, each GPL class consists of 
numerous structurally different molecular species and thus a eukaryotic cell contains thousands 
of different GPL molecules [4-7]. The meaning of such diversity is not fully understood, but 
probably relates to the multiple functions of GPLs [1, 3, 4]. GPLs are the major components of 
all cellular membranes, but their relative abundances vary significantly from one organelle to 
another [3]. For example, the inner mitochondrial membrane is enriched in PE, but contains 
very little PS due to the presence of the PS decarboxylase [8]. On the other hand, PS is 
abundant in the inner leaflet of the plasma membrane, where it may serve to activate 
membrane-associated enzymes, such as protein kinase C, as well as assist in membrane fusion 
[9]. Only CL and bismonoacylglycerophosphate are synthesized at the location they are found, 
i.e. mitochondria and lysosomes, respectively. All other GPLs have to be transported from their 
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site of synthesis in the ER or the Golgi to other organelles. The mechanisms and regulation of 
intracellular GPL transport are not well established. 
 
Beside their role as key structural components of membranes, GPLs serve also several other 
important cellular functions. For example, the GPL precursor lysophosphatidic acid is a potent 
mitogen [2]. Many GPLs are involved in cellular signaling as sources of arachidonic acid, a 
precursor of prostaglandins and other leukotrienes [2]. Polyphosphoinositides regulate a 
plethora of cellular phenomena [10] and PI is part of the GPI-anchors which mediate the 
association of certain proteins to the outer leaflet of the plasma membrane [11]. Cardiolipin is 
necessary for proper functioning of the enzymes of inner mitochondrial membrane carrying out 
oxidative phosphorylation [12]. 
 
Higher eukaryotes maintain the concentrations of their membrane GPLs within narrow limits 
[13], implying that deviations from the optimum composition are deleterious. Consistently, 
hardly any GPL-related genetic diseases exist in humans, probably because mutations in the key 
enzymes catalyzing the key biosynthetic or degradative reactions are fatal. This conclusion is 
supported by the fact that knock-outs of the key enzymes of phospholipid biosynthesis are 
embryonic-lethal or compromise vital functions in mice [14]. In addition, many GPLs are 
synthesized via more than one pathway and many key enzymes are encoded by multiple genes 
[14], which indicates that during evolution mammals have developed alternative mechanisms 
to ensure adequate synthesis of each GPL under all conditions. Despite the vital importance of 
GPL homeostasis, information regarding the mechanisms underlying this phenomenon in 
mammalian cells is scarce. Four processes contribute to the cellular GPL homeostasis: 1) 
biosynthesis, 2) remodeling, i.e. exchange of a fatty acid (FA) residue, 3) degradation and 4) 
interorganelle transport. Little is known about the coordination of these processes. Such 
coordination is essential for instance to prevent futile competition between synthesis and 
degradation. Beside the complexity of the phenomenon itself (see below), understanding the 
regulation of the key processes has been hampered by the lack of methods allowing detailed 
and comprehensive analysis of the metabolism of different GPLs and their various 
intermediates. However, owing to its great resolving power and sensitivity, mass spectrometry 
(MS) has changed all this by allowing rapid and detailed analysis of complex biological samples. 
Especially when used together with stable isotope-labeled precursors, MS has opened 
completely new avenues for studies on GPL homeostasis.  
 
The aim of this thesis was to develop mass-spectrometric methodology for analysis of 
glycerophospholipids and their metabolism in mammalian cells. These tools were then applied 
to investigate how mammalian cells maintain the GPL-compositions of their various 
membranes.  
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2. REVIEW OF THE LITERATURE 
 
2.1. GLYCEROPHOSPHOLIPID HOMEOSTASIS IN MAMMALIAN CELLS    
As discussed above, four different processes contribute to the cellular GPL homeostasis: 
biosynthesis, remodeling (exchange of fatty acid residues), degradation and interorganelle 
transport. I will next briefly discuss each of these processes. 
 
 
2.1.1 Biosynthesis 
 
The synthetic pathways for the major mammalian GPLs have been elucidated [15] and are 
depicted in Fig. 2. GPL biosynthesis is reviewed in depth in publication V, and thus discussed 
here only briefly. The first GPL in the pathway is phosphatidic acid (PA), which is synthesized 
from glycerol-3-phosphate via sequential acylation of the sn1 and sn2 hydroxyl groups by 
glycerol-3-phosphate acyltransferase and acylglycerol-3-phosphate acyltransferase, 
respectively. Beyond PA the pathway diverts to two main branches: one that leads to formation 
of the acidic GPLs i.e. PI, phosphatidylglycerol (PG) and CL via CDP-diacylglycerol; and the other 
where PA is dephosphorylated by a PA phosphatase (PAP) to diacylglycerol (DAG), which then 
serves as a precursor of PC, PE and PS. DAG can also be converted to triacylglycerol (TAG) which 
serves a reservoir or buffer of DAG and fatty acids.  
 
 
 
 
   
 
 
                             
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2. Pathways of glycerophospholipid biosynthesis in mammalian cells. The key metabolites (in black) and 
the enzymes catalyzing the respective reactions (in red) are indicated. The abbreviations are specified in 
publication V.  
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2.1.2. Acyl chain remodeling  
 
After their synthesis de novo, most GPL species undergo a process called acyl chain remodeling, 
which involves phospholipase A-catalyzed removal of a fatty acid from either the sn1 or sn2 
position of the glycerol and acyl transferase or transacylase -mediated reacylation of that 
position with a different fatty acid (Fig. 3A) [16-19]. GPL remodeling is involved in establishing 
and maintaining the specific molecular species composition of the various GPL classes. Acyl 
chain remodeling is required, e.g., for arachidonic acid -dependent signaling [17], activation of 
enzymes in the inner mitochondrial membrane [20], alveolar surfactant synthesis [21, 22], exo- 
and phagocytosis [23, 24], repair of oxidized phospholipids [25, 26], and regulation of 
membrane "fluidity" [27]. Remodeling of CL has received particular attention because defects in 
this process compromise the functionality of mitochondria [12, 28, 29].  
 
A-type phospholipases (PLAs) are key enzymes of GPL remodeling since they catalyze the 
committed step of this process. A multitude of PLA proteins exist [30], but the ones involved in 
GPL remodeling have not been identified. However, Ca2+-independent PLAs (iPLAs) as well as 
cytosolic phospholipases (cPLAs) could be involved [31-34]. Beside the lack of information on 
the identity of the PLAs involved, it is unclear how these enzymes recognize the molecular 
species to be remodeled.  
 
 
  
P
HG
P
HG
P
HG
P
HG
P
HG
Acyl-
transferase
PLA2PLA1
Lyso-PLA
P
HG
P
PLC
PAPPLD
A B
 
 
 
 
Figure 3. Phospholipase -catalyzed reactions potentially involved in GPL homeostasis. A. A-type phospholipases 
(PLA1 or PLA2) cleave either the sn1 or sn2 ester bond thus producing a lyso-GPL and a free fatty acid. The lysolipid 
is then either reacylated with a different fatty acid by acyltransferase to complete remodeling, or is degraded by a 
lysophospholipase to water-soluble lipid "backbone" such as glycerophosphocholine. B. Phospholipase D (PLD) 
cleaves the bond between the phosphate (P) and the head group (HG) thus producing phosphatidic acid PA, which 
can be dephosphorylated by phosphatidic acid phosphatase to yield DAG. PLC hydrolyzes the ester bond between 
the phosphate and the glycerol backbone thus yielding DAG directly.   
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The lyso-GPLs formed via the action of a PLA1 or PLA2 can be either reacylated by an acyl 
transferase to reform an intact phospholipid or they can be hydrolyzed by a lysophospholipase 
to a water-soluble GPL "backbone" and a fatty acid (Fig. 3A). It is a crucial but yet unresolved 
question how the fluxes via these alternative paths are regulated. 
 
Two families of lysophospholipid acyltransferases that are involved in phospholipid remodeling 
have been identified (reviewed in [19]). These acyltransferases use acyl-CoA as acyl group 
donors and show varying specificity towards the acyl-CoA [35] and can also discriminate 
between lysophospholipids with an ester vs. alkyl or alkenyl-linked chain [35, 36]. Beside CoA-
dependent acyltransferases, reacylation of lysophospholipids can be accomplished by CoA-
independent acyltranferases and transacylases [17, 37, 38]. Little is known of the regulation of 
acyltransferases and other enzymes involved in acylation of lysoGPLs. 
                      
Despite its crucial role in several important biological processes, many aspects of 
glycerophospholipid remodeling remain unresolved. For example, to what extent does acyl 
chain remodeling contribute to the steady state phospholipid compositions of cells or their 
subcellular organelles? What are the molecular characteristics rendering a phospholipid 
molecule susceptible for remodeling, i.e., how do the phospholipases involved recognize their 
targets? Are there specific phospholipases for each phospholipid class, or even for different 
species within a class? Which acyltransferases are involved? Where does the hydrolysis and 
reacylation take place? How are remodeling and degradation (turnover) coordinated? A key 
problem in resolving these issues has been the lack of suitable methods.  
 
Early studies on phospholipid remodeling were carried out by incubating cells with radiolabeled 
GPL precursors e.g. fatty acids, glycerol, choline or ethanolamine. The radiolabeled molecular 
species were then separated by reversed-phase liquid chromatography, followed by chemical 
or phospholipase-mediated hydrolysis of the acyl residues which were then identified by gas-
chromatography [16, 39-41]. Such methods are very laborious and insensitive and provided 
only limited information of GPL acyl chain remodeling. More recently, MS combined with stable 
isotope-labeled precursors has proven a convenient tool for such studies [24, 42-45]. However, 
even with this approach it is impossible to resolve reliably the remodeling pathways and 
kinetics individual species because numerous molecular species are labeled already during the 
pulse [42, 43, 46-48]. Thus, novel approaches are required to elucidate the mechanisms of GPL 
remodeling, including the identification of the specific phospholipases and acyltransferases 
involved.  
 
 
2.1.3. Degradation  
 
Degradation plays a major role in GPL homeostasis as indicated by rapid (and selective) 
turnover of GPLs. For example, the half-life of PC is only 2 - 4 h in actively proliferating cells [49, 
50]. GPLs are also hydrolyzed in response to various extracellular stimuli to generate precursors 
for second messengers [10, 51, 52]. As compared to biosynthesis, surprisingly little is known 
about degradation of phospholipids. For example, the intracellular site, the enzymes involved 
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and their relative contributions to GPL turnover remain elusive. It is clear that phospholipids 
destined to lysosomes are degraded therein, but the contribution of the lysosomal pathway is 
rather low and thus most of GPL degradation is catalyzed by nonlysosomal phospholipases [53]. 
Depending on the bond they cleave (Fig. 3), phospholipases are divided in three groups, i.e. 
phospholipases A (PLAs), C (PLCs) and D (PLDs).  
 
PLAs release the fatty acid in the sn1 or sn2 position of the glycerol moiety thus producing a 
lysophospholipid and a free fatty acid. The lysoGPL formed is either reacylated to form new GPL 
molecule, or is degraded by a lysophospholipase (Fig.  3A). PLAs form a large protein 
superfamily consisting of 15 different groups [54], and currently 24 different genes encoding for 
mammalian PLAs have been identified. PLAs play a crucial role a multitude of other cellular 
phenomena [30]. PLAs are key players in GPL remodeling [13] and probably in GPL class 
homeostasis as well, since much of GPL turnover seem to be mediated by PLAs [55, 56]. 
However, the specific PLAs involved here have not been established, albeit some Ca2+-
independent PLAs (iPLAs) have been implicated.  
 
PLCs hydrolyze the bond between phosphate and glycerol backbone to produce DAG and a 
phosphorylated head group (Fig. 3B). PLCs are commonly thought to be involved in signal 
transduction [57, 58], rather than phospholipid homeostasis. However, some studies support 
the involvement of PLCs in GPL homeostasis. For example, Minahk and co-workers showed that 
when [3H]-PC in LDL particles was taken up by rat hepatocytes, 50% of the cell-associated [3H]-
PC was hydrolyzed to [3H]-DAG (presumably by a PLC) which was then converted to TAG [59]. 
Analogous results were obtained for [3H]-PC taken up from HDL particles [60]. PLCs were also 
implicated in the turnover of PE and PC derived from exogenous [3H]-lysoPC and -PE [61, 62]. 
 
PLDs hydrolyze the bond between the phosphate and head group of a GPL thus producing 
phosphatidic acid (PA) and a free head group (Fig. 3B). Like PLCs, PLDs are considered to be 
involved mainly in signal transduction [51, 52], and there seems to be no published data linking 
these proteins to GPL homeostasis. However, many PLDs catalyze in vitro 
transphosphatidylation reactions in which a GPL is converted to another with a different head 
group. Intriguingly, PS synthases catalyze a reaction analogous to PLD by replacing the group of 
PC or PE with serine [15] and also catalyze the reverse reaction. Thus they and other PLD-like 
enzymes could play an important role in GPL homeostasis by catalyzing the interconversions of 
different GPL classes.      
 
 
2.1.4. Regulation of GPL metabolism 
 
Remarkably little is known of how GPL synthesis and degradation are coordinated. Such 
coordination is essential to avoid futile (energy-wasting) competition between these opposite 
processes. As implied by Fig.  4, the maintenance of GPL homeostasis in mammalian cells is a 
formidable task because the biosynthesis and degradation of the many different phospholipid 
classes have to be coordinated precisely. 
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Figure 4. Hypothetical model for the maintenance of cellular GPL class homeostasis. The synthesis and degradation 
each GPL class could be coordinated by specific regulators, which in turn are coordinated by a “grand regulator” 
(noted by ?). The identities of the regulatory factors remain unknown. Reprinted with permission from publication 
V. 
 
Compelling evidence for strict coordination of GPL synthesis and degradation comes from 
studies in which the synthesis of a GPL class was boosted by over-expressing the rate limiting 
enzyme. For instance, overexpression of CTP:phosphocholine cytidylyltransferase in HeLa cells 
increased phosphatidylcholine (PC) synthesis 4-5 fold, but the PC content of the cellular 
membranes remained essentially constant. However, greatly increased amounts of 
glycerophosphocholine, a deacylation product of PC (but not of other GPLs) were detected in 
the cells and the culture medium [62, 63]. Analogously, forcing the synthesis of PE or PS did not 
significantly increase the cellular content of the lipid, but increased their deacylation [64, 65]. 
Conversely, when the synthesis of a GPL is downregulated, its degradation decreases in 
proportion to maintain homeostasis. For example, in CHO mutants with partially inactive 
choline kinase ?, the rate of PC synthesis was reduced 4-fold, but the PC content was normal 
[66]. Analogously, when PE synthesis in cells was strongly inhibited by mutating 
ethanolaminephosphotransferase, the PE did not decrease because its turnover was reduced in 
proportion [67]. 
 
The findings discussed above indicate that GPL synthesis and degradation in mammalian cells 
are strictly coupled. They provide compelling evidence that mammalian cells contain 
phospholipases which selectively degrade the GPL present in excess, consistent with the model 
suggesting that specific regulatory circuits exist for each GPL classes (Fig. 3). However, it is not 
obvious how those phospholipases are regulated so that they degrade only the GPL in excess, 
but not more. An answer to this intriguing question could be provided by the superlattice model 
to be discussed below. 
 
Synthesis  ? PC ? Degradation                   Synthesis  ? PE ? Degradation
Coordination? Coordination?
?
Coordination? Coordination?
Synthesis  ? PS ? Degradation                    Synthesis  ? PI ? Degradation
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Superlattice formation - It is possible that composition-dependent changes in the lateral 
organization of membranes regulates both phospholipid synthesis and degradation, thus 
coordinating these opposing processes. This idea is based on the predictions of a superlattice 
model (SL-model) of membrane organization (reviewed in [68, 69]). The SL-model is most 
relevant to GPL homeostasis for two reasons. First, the model predicts the existence of a 
limited number of “critical” (allowed) compositions, which are energetically more favorable 
than the intervening compositions. Accordingly, the lipid composition of a membrane has an 
intrinsic tendency to settle in one of the critical compositions, thus serving as a natural set 
point. Another important prediction of the SL-model is that when the concentration of a 
phospholipid exceeds a “critical” value, membrane packing defects appear, since the molecules 
in excess cannot be accommodated in the existing superlattice. The lipid species in excess 
would thus be forced to form separate domains and, consequently, domain boundaries with 
packing defects appear. It is well established that many phospholipases are strongly activated 
by bilayer packing defects (reviewed in [70]) and thus they could activate homeostatic 
phospholipases as well, thus leading to degradation of the lipid species present in excess. When 
the species in excess has been hydrolyzed, the defects disappear and the hydrolysis stops. 
Accordingly, SL formation could provide a highly accurate regulation and coordination of the 
putative homeostatic phospholipases acting on different phospholipid classes (Figure 4). 
Evidence for regulation of a venom PLA2 by superlattice formation has been obtained [71]. 
Notably, the predicted abrupt changes in membrane organization could also regulate the 
activity of key biosynthetic enzymes [68]. The best evidence for that SL formation is involved in 
phospholipid homeostasis comes from a study showing that the phospholipid compositions of 
erythrocytes (and platelets) from different species coincide remarkably well with those 
predicted by the SL-model [72].  
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2.2. ANALYSIS OF GLYCEROPHOSPHOLIPID COMPOSITIONS 
 
Since the discovery of phospholipids in the 19th century a multitude of different methods for 
their analysis has been developed. While most common methods are based on different forms 
of chromatography, i.e., thin-layer chromatography (TLC), high performance liquid 
chromatography (HPLC) and gas chromatography (GC), also spectroscopic methods, especially 
nuclear magnetic resonance (NMR) spectroscopy, have provided important information about 
structure of phospholipids and membranes. During the past two decades, mass spectrometry 
(MS) has emerged as the method of choice for lipid analysis due to its high selectivity, 
sensitivity as well as simplicity. I will briefly review the main analytical approaches employed to 
investigate mammalian lipid compositions with a particular emphasis on MS. 
 
 
2.2.1. Traditional methods 
 
 
2.2.1.1. Thin-layer chromatography  
 
Thin-layer chromatography (TLC) was one of the first methods used for phospholipid analysis 
and is still widely used [73]. In TLC the analytes are separated based on their differential 
partitioning between a liquid mobile phase and a liquid stationary phase on a solid support 
which usually consists of silica gel particles attached to a glass or plastic plate. The silica can be 
modified in various ways to improve separation of phospholipid classes [73]. The eluent is a 
mixture of organic solvents (usually chloroform and methanol) and water with various 
additives, i.e., salts, acids or bases.  
 
The sample solutions are applied as spots or bands on the TLC-plate which is then placed in 
chamber containing the solvent eluent. Phospholipid classes will migrate with the eluent and 
separate from each other due to differential partitioning between the mobile and stationary 
phases [74]. TLC can be carried out in either one or two dimensions. The latter uses two 
different solvent mixtures and provides better separation of the classes, but only one sample 
can be applied to a plate [73, 75].  
 
Iodine vapor is probably most commonly used to visualize phospholipids on TLC plates, but 
does not work well with saturated lipids. It also covalently modifies the double bonds of 
unsaturated lipids, which precludes their further analysis by e.g., gas-chromatography or mass-
spectrometry [73, 76]. GPLs can be selectively visualized with phosphate stains, the ones based 
on a molybdate reagent being most common [75, 77]. Fluorescein or rhodamine stains can be 
used to detect GPLs by UV light. Charring is yet another common method to detect GPLs and 
other lipids on TLC plates [75, 78].  
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While TLC is a simple and inexpensive method to separate and quantify of phospholipid classes, 
it has several shortcomings. The main one is that it does not provide resolution of the individual 
molecular species. Second, hydrolysis or oxidation of the phospholipids can occur thus biasing 
the data [79]. TLC also has rather poor sensitivity and low resolution compared to other 
methods, particularly mass-spectrometry [77]. Finally, TLC cannot be readily automated, 
although robots for semi-automated lipid analysis exist [73].  
 
 
2.2.1.2. Gas-liquid chromatography 
 
Gas-liquid chromatography, or more commonly gas chromatography (GC), is another form of 
partition chromatography in which volatilized compounds are passed in a stream of a carrier 
gas through a column containing a high boiling point liquid (a stationary phase) on a solid 
support [80]. The compounds separate based on their differential partitioning between the 
mobile carrier gas and stationary liquid phase. The most common mode of detection is that 
based on flame ionization which is highly sensitive and has low background [81]. GC can also be 
coupled to a MS detector, which provides important additional information on the analytes [82, 
83]. Obviously, GC can only be used to analyze compounds that can be vaporized without 
decomposition. Since GPLs are not volatile, their direct analysis by GC is not possible but they 
must be first hydrolyzed by PLC to diacylglycerol, which is then derivatized to form a more 
volatile compound [80].   
 
Typically, GC has been used to determine the fatty acid composition of phospholipid classes 
after their separation by TLC [84]. While this approach is still in use, it requires large amounts of 
starting material, is time consuming and laborious. Hence most investigators use alternative 
techniques, particularly mass-spectrometry. The most useful application of GC today is the 
analysis of free fatty acids [83].  
 
 
2.2.1.3 Liquid chromatography  
 
Like TLC, liquid (column) chromatography (LC), separates the analytes based on their 
differential partitioning between a liquid mobile phase and a liquid stationary phase which 
resides on the surface of particles packed in a steel or glass column. Modern LC utilizes very 
small particles, which necessitated the use a relatively high elution pressure, and thus the term 
“high pressure (or performance) liquid chromatography” (HPLC) was introduced [85]. HPLC was 
first used to separate phospholipids in 1975 [86] and ever since a vast number of studies have 
used this method. Recently, so-called ultra performance liquid chromatography (UPLC) was 
introduced. In UPLC the particles are very small and thus a very high pressure has to be used to 
obtain a reasonable rate of elution. The major benefits of UPLC are short elution times and high 
resolution  [87].  
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In LC two different separation modes are used: (i) normal phase LC, which separates GPL classes 
based on the structure of the head group and (ii) reverse phase  LC (RPLC) which separates the 
molecular species (mainly) based on the hydrophobicity of the alkyl chains [88]. Full separation 
of GPL species is not possible with RPLC only, since the molecular species in different lipid 
classes (e.g. PC, PE and PS) tend to coelute. Thus prior separation of the classes by normal-
phase LC is necessary, unless mass-spectrometric detection is available (see below).   
 
Traditional LC detection methods are those based on absorbance, refractive index, light-
scattering, electrochemical, suppressed conductivity and mass spectrometry [81, 89, 90]. 
Among these, evaporative light scattering has become popular because its response is nearly 
independent of the molecular structure [89]. However, MS detection is by far the most 
sensitive one and also provides structural information not obtainable with any other detection 
method. Thus, in current GPL analysis LC is mainly used in combination with a MS detector as 
discussed below (2.2.2.4).  
 
 
2.2.1.4. Nuclear magnetic resonance spectroscopy 
 
Nuclear magnetic resonance (NMR) spectroscopy allows elucidation of GPL structures, as well 
as their quantitative analysis in complex samples [91, 92]. A particular virtue of NMR is that it 
allows the analysis of GPL compositions of tissues in vivo [92, 93]. Another advantage of NMR is 
that it allows one to determine the position of the double bond in the alkyl chain and 
differentiate between cis/trans isomers [94]. NMR is also useful for characterizing lipid-lipid and 
lipid-protein interactions and dynamics in membranes [95, 96]. NMR is not commonly used to 
analyze complex lipid mixtures, mainly due to its low sensitivity and complication due to 
overlap of [13C] and [1H]-NMR signals. This problem can be partially circumvented by the use of 
heteronuclear single quantum coherence NMR which provides a 2-D lipid map [97, 98]. From 
such maps, differences between samples can be resolved and the differentiating compounds 
identified and quantified. Thus, heteronuclear single-quantum correlation NMR could be used 
for e.g. lipid biomarker discovery [97]. NMR studies have also been used to demonstrate that 
choline lipid metabolism is significantly altered in various tumors [99] and thus NMR-based 
lipidomics may be utilized in diagnosis [100].    
 
 
2.2.2. MASS-SPECTROMETRIC LIPID ANALYSIS 
 
Advances in mass spectrometry have revolutionized the analysis of lipid compositions of cells 
and other biomaterials by simplifying the analytical protocol dramatically and by increasing the 
sensitivity of detection by several orders of magnitude. Instrument development and intense 
research have brought this method to a level where identification of up to 1000 individual lipid 
species present in a single sample is possible [101-103]. Consequently, a new field of lipidomics 
emerged. Lipidomics is a branch of metabolomics that aims at the quantitative molecular 
characterization of the full lipid complement (known as a lipidome) of cells, tissues or whole 
organisms in order to determine the biological functions of those lipids [4, 5, 7, 104-106]. 
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However, as eukaryotes are estimated to contain 104 to 105 individual molecular lipid species 
belonging to dozens of lipid classes [6], we are still far from reaching this objective. Two main 
analytical strategies have been adopted for lipid analysis by MS: (i) direct infusion MS (DI-MS) 
or the so-called “shotgun” approach and (ii) LC-MS using on-line LC separation prior to MS 
analysis [7, 107]. In addition, mass-spectrometric imaging of lipids in tissues has recently 
become available. These approaches will be discussed in more detail below, after introduction 
to the basic principles of mass spectrometry.  
 
 
2.2.2.1 Principles of mass spectrometry 
  
Mass spectrometry is based on separation of gas phase ions in magnetic and electrical fields. An 
MS instrument typically comprises of four components: i) an inlet for sample introduction, ii) an 
ion source to generate ions, iii) a mass analyzer and iv) a detector. In the ion source, molecules, 
unless already charged, are converted to positively or negatively charged ions. Then these ions 
are separated on the basis of their mass-to-charge-ratio (m/z) by the mass analyzer before 
being detected. The primary output of an MS instrument is a mass spectrum where the 
abundance (or intensity) of the ions are plotted as a function of their m/z (FIGURE 5). Additional 
dimensions to the data can be obtained by, e.g., preseparation of the analytes by LC on-line 
(FIGURE 6), or by collision-induced dissociation of the analytes (see below).     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5. A Mass spectrum. The primary output of a mass spectrometer is a mass spectrum, where the m/z of 
recorded ions is displayed on the x-axis and their intensity (counts) on the y-axis. This spectrum  was obtained from 
a HeLa cell lipid extract by NL141 scanning, which specifically detects diacyl PE species (see below).  Unpublished 
data. 
 
There are numerous types of mass spectrometers with different types of ion sources and/or 
mass analyzers. Electrospray ionization (ESI), atmospheric pressure chemical ionisation, matrix-
assisted laser/desorption ionisation (MALDI) and electron ionisation are the most commonly 
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used ionisation techniques [108, 109]. The most common mass analyzers are the quadrupole 
(Q), ion trap, time-of-flight (TOF), Fourier transform ion cyclotron resonance and Orbitrap, each 
of which has its specific advantages [108, 110]. Typically lipid profiling is conducted on tandem 
mass spectrometers, which consist of two mass analyzers separated by a collision cell. 
Structural information on the lipids is obtained by fragmenting them (see below) by collision-
induced dissociation (CID). The techniques used to record these fragmentation reactions are 
called tandem MS (MS/MS) or MSn. Typical MS/MS instruments include triple quadrupoles and 
quadrupole-TOFs (QTOF). Ion-trap-type instruments are capable of multistage MS (MSn), in 
which multiple consecutive fragmentations can be carried out. Detailed description of all types 
of ionization methods and MS-analyzers is out of the scope of this thesis, but can be found on 
recent books and reviews [108, 109]. I will briefly introduce the methods pertinent to the 
current work, namely electrospray ionization and triple quadrupole mass analyzer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6. A three-dimensional display of liquid chromatography-mass spectrometric dataset obtained from a 
mouse brain extract. m/z is displayed on the x-axis, ion intensity on the y-axis and time on the z-axis. Projection of 
the time dimension (blue) = total ion chromatogram. Projection of the m/z dimension (red) = total ion spectrum. 
Reprinted with permission from (Hermansson et al. (2005), Anal Chem 77, 2166-75). Copyright (2005) American 
Chemical society.    
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Electrospray ionization (ESI) is the most commonly used ionization technique in mass 
spectrometric analysis of lipids [111]. In ESI, ions are generated at atmospheric pressure by 
introducing analytes in solvent through a small capillary set to high potential (voltage) relative 
to the MS analyzer entrance [109, 112]. A strong electric field drives formation of a fine spray of 
charged droplets [113, 114]. Evaporation of the solvent progressively increases the charge 
density at the surface of those droplets leading to their fission to smaller droplets and, 
eventually, gas phase ions which are pulled to the MS-analyzer by the electric field [113, 114].  
 
 
 
 
 
 
 
 
 
FIGURE 7. The mechanism of electrospray ionization.    
 
 
Partitioning of the molecules between the surface and the interior of the droplets depends on 
their polarity and other properties [115, 116]. As the ionization process occurs at the surface of 
the droplet [117], such a behavior results in unequal ionization of molecules in complex 
mixtures. Furthermore, easily ionizable impurities, such as salts, detergents or other surface-
active molecules can cause significant suppression in ionization of the analytes because such 
molecules tend displace the analytes from the surface of the droplets thus reducing the 
efficiency of their ionization [118]. This “ion suppression” complicates quantification, since the 
ion intensity does not depend solely on the concentration of the analyte, but is also affected by 
the concentrations of other molecules in the sample [115]. Beside impurities, also analytes can 
suppress the ionization of each other [117] and thus it is useful to operate at as low sample 
concentrations as possible.   
 
In the positive ionization mode, ESI produces protonated molecular cations ([M + H]+) or 
adducted cations (e.g. [M + Na]+ and [M + NH4]
+ ), while deprotonated molecular anions ([M ? 
H]?) and anion adducts (e.g. [M + Cl]? and [M + CH3COO]?) are observed in the negative mode. 
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In the case of phospholipids, the zwitterionic PC, SM and PE are best analyzed as [M+H]+ ions 
and the acidic phospholipids, PS, PI, PA, PG and CL as [M-H]- ions. 
 
Triple quadrupole mass spectrometer has three quadrupoles (Q) in sequence (Figure 8). The 
first and third quadrupoles (Q1&Q3) act as mass filters that separate ions, while the second 
quadrupole (Q2) functions as a collision cell where ions can be fragmented upon collision with 
neutral gas molecules, e.g. argon. A quadrupole is composed of four precisely matched parallel 
metal rods (Figure 8). Direct current and radio frequency potentials are applied to these rods to 
produce an oscillating electric field. By varying the direct current and radio frequency 
potentials, ions of a specific m/z value is allowed pass through the quadrupole. Quadrupoles 
can be operated in three modes: 1) all ions with m/z within a certain range (e.g. 500-1000) can 
be transmitted simultaneously, 2) ions of a narrow m/z range (e.g. 1 Da) can pass the analyzer 
or 3) ions are sequentially passed through the quadrupole in small intervals (e.g. 0.2 Da), i.e. 
the analyzer “scans”.   
 
 
source Q1 Q2 (collision cell) detectorQ3  
 
FIGURE 8. A diagram of a triple quadrupole mass spectrometer. 
A triple quadrupole mass spectrometer is particularly well suited for lipidomics because it 
allows for several modes of MS/MS, including product ion, precursor ion and neutral loss 
scanning as well as selected reaction monitoring (Figure 9). In product ion scanning, an ion with 
a given m/z is selected by MS1 (Q1), fragmented in the collision cell by collision-induced 
dissociation (CID) and daughter (product) ions formed are analyzed by scanning MS2 (Q3). In 
precursor ion scanning, MS2 is set to transmit a defined fragment ion, e.g. a phosphocholine 
ion with a m/z of 184 while MS1 is scanned. In this way only the molecules that give the select 
fragment ion are detected, i.e. PC and SM in this case. In a neutral loss scan MS1 and MS2 are 
scanned in tandem with a constant offset, e.g.  141 Da, to detect the loss of the 
phosphoethanolamine group from PE. To obtain maximum sensitivity, selected reaction 
monitoring (SRM) can be performed. In SRM the MS1 transmits only the precursor ion of 
interest and MS2 transmits only a specific fragment ion. As neither quadrupole is scanned, time 
is not wasted on the acquisition of irrelevant ions and thus a high sensitivity of detection can be 
achieved. Multiple SRMs can be programmed in the instrument software, thus allowing for 
multiple reaction monitoring. 
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FIGURE 9. The MS/MS modes available in a triple quadrupole mass analyzer.  
 
 
2.2.2.2. Fragmentation of GPLs  
 
GPLs consist of a polar head group, the glycerol backbone and two alkyl chains and CID of GPLs 
creates many informative fragments (Figure 10). Those deriving from the head group are 
particularly useful since they allow for specific detection of the various GPL classes based on 
specific precursor ion or neutral loss scans. As noted above, CID of [M+H]+ ions of PC generates 
a characteristic phosphocholine head group fragment ion with a m/z 184 and thus, PC 
molecules can be detected by scanning for the precursors of m/z 184 on a tandem MS 
instrument [119, 120]. However, since also SM gives this characteristic fragment, SM are also 
detected by such scans [119]. [M+H]+ ions of PE and PS lose the head group  
(phosphoethanolamine and -serine, respectively) as a neutral fragment thus allowing their 
specific detection by scanning for neutral loss of 141 or 185 Da, respectively [119, 120]. 
Fragmentation of molecular anions of PI in the negative mode produces a negatively charged 
phosphoinositol fragment with m/z 241 [119, 120], thus allowing selective detection of PI by 
scanning for the precursors of m/z 241. Also PS can be detected in the negative mode by 
scanning for the neutral loss of 87 Da, i.e. serine. [119]. A specific scanning mode exists also for 
phosphatidylglycerol [121], but unfortunately not for e.g. PA or CL [121]. These lipids can be 
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detected by scanning for the precursor of glycerophosphate (m/z 153) in the negative mode, 
but also other negatively charged lipids are detected using this mode. 
    
 
 
Figure 10: Fragmentation of glycerophospholipids by CID provides structural information and allows specific 
detection of most phospholipid classes.  The dotted lines indicate the most labile bonds from which fragmentation 
most frequently occurs.   
 
 
Although the MS/MS scans described above allow for selective and sensitive detection of GPL 
species belonging to the various GPL classes, they do not provide direct information on the alkyl 
substituents or their sn positions, but only on the total number of carbon atoms and double 
bonds present in the molecule. Thus, such scans fail to distinguish between isomeric (e.g. 
species with same acyl substituents but in reverse sn positions, like 16:1/18:1 and 18:1/16:1) 
and isobaric species (e.g. species with same total carbon double bond number but different acyl 
moieties, like 18:1/18:1 and 18:0/18:2). Such information can be obtained by analyzing the 
products formed upon CID-induced cleavage of the ester bonds linking alkyl chains to the 
glycerol moiety (Figure 10). CID of molecular anions or anion adducts of GPLs yields three main 
types of product ions: i) fatty acid carboxylate anions, ii) lysoPL formed upon neutral loss of a 
fatty acid residue as a ketene and iii) a lysoPL-like lipid due to neutral loss of a free fatty acid 
[121]. The relative intensities of these fragments depend on the sn position of the fatty acid 
moiety in the glycerol backbone and can thus be used to assess their sn positions [121]. 
Identification of the positions of the double bonds in the GPL acyl chains by ESI-MS is generally 
not straight-forward. However, MSn of GPL lithium adducts [122] and chemical derivatization by 
osmium tetroxide [123] or ozone [124, 125] have been successfully used to identify the double 
bond positions in phospholipids. 
 
 
2.2.2.3. Direct infusion mass spectrometry 
 
Direct infusion MS of a crude lipid extracts is often called “shotgun lipidomics”. Three principal 
shotgun approaches are commonly used. One of these is based on so-called intrasource 
separation of lipid classes [126], which takes advantage of the varying propensity of the 
different lipid classes to form ions in an electric field. By judicious choice of solvents, additives 
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and source polarity, all major lipid classes can be directly quantified without chromatographic 
separation. Tandem MS, e.g. product ion/neutral loss scanning, allows identification of the alkyl 
residues of the quantified species and estimation the ratio of isobaric molecular species [126].  
 
Another commonly used approach relies on quantification of the GPL classes and species by 
head group-specific scanning modes i.e. precursor ion and neutral loss scanning discussed 
above [119, 120]. This methodology is highly sensitive for identifying and quantifying the major 
phospholipids, but does not allow selective detection of some lipid classes, e.g. PA, CL and 
neutral lipids, for which there is no specific detection mode based on fragmentation. Also, the 
method does not provide direct information on the fatty acyl constituents which need to be 
identified by separate product ion neutral loss scans.   
 
The third shotgun approach is based on multiple precursor ion and neutral loss scanning (MPIS). 
MIPS is a powerful tool for analysis of GPL compositions, since it allows for simultaneous 
identification of the head group as well as the acyl substituents and their sn positions [127-
129]. MPIS is nowadays often used together with automated chip-based nanospray ESI-source 
(Advion NanoMate) and a high resolution QTOF or Orbitrap tandem mass spectrometer [101, 
130, 131]. The sample is infused at a very slow flow rate (few nl/min), which provides a reduced 
background noise and extended acquisition time, which allows for many products ion scans 
from a small sample. Nanospray ionization is also less prone to suppression effects, presumably 
because the smaller size of the droplets allows a larger fraction of the ions to occupy the 
surface and thus enter the analyzer [117, 129]. The product ion spectra can be searched for 
structure specific fragment ions or neutral losses that correspond to characteristic fragments of 
a lipid molecule, e.g. fatty acid or head group. The high resolution of TOF or Orbitrap mass 
analyzers allows the fragment ion or neutral loss to be accurately specified, which reduces  
misidentification of some lipids that could occur with instruments operating at a lower 
resolution [127]. The MPIS experiments produce very complex data sets which require specific 
software for the analysis [6, 128].  
 
The shotgun approaches are relatively simple and have the advantage over LC-MS that the 
electrospray conditions remain constant, i.e. the solvent composition, matrix and sample 
concentration which can affect the ionization of analytes do not change during the run. Thus 
quantification of the lipids is more straightforward with this approach. However, this technique 
suffers from ion suppression and the inability to distinguish many isomeric or isobaric species.  
Consequently, if one is after the best sensitivity and selectivity, the LC-MS approach is often a 
better choice.   
 
 
2.2.2.4. Liquid chromatography-mass spectrometry  
 
Another commonly used approach for lipid analysis employs liquid chromatography with mass 
spectrometric detection (LC?MS) [132, 133] in which a HPLC (or UPLC) instrument equipped 
with a normal or reverse-phase column is coupled to an ESI-MS-instrument. A particular benefit 
of LC is that solvent entering the MS instrument at any given time contains only a few species, 
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which minimizes ion suppression and reduces interferences by isomers, isobars, and isotopes 
[7, 133]. This improves the sensitivity of detection as compared to DI-MS, thus allowing more 
facile detection of minor species. Another important advantage of LC-MS is that elution order 
of the analytes from the LC column provides information which can help in identification of 
lipids [132]. 
 
Normal phase LC provides separation of the GPLs based mainly on their head group [134-136]. 
Since all molecular species in a class eluted within a narrow time window together with the 
internal standards, accuracy of quantification is improved as compared to RP-LC where there is 
a wide spread of elution times in a class (see below). Usually, normal phase LC-MS is carried out 
in negative mode, which allows facile detection of PA, PE, PS, PI, CL as [M-H]- ions. PC and SM 
can be detected as formate or chloride adducts [134-136].  
 
Reversed-phase LC separates GPL molecules based on their fatty acyl chains rather than the 
head groups. Thus RP-LC can separate more molecular species than normal phase [135]. 
However, there is often a major overlap between species in the different classes (and 
standards), which can significantly bias the data due to ion suppression effects. In the case that 
gradient elution is used solvent composition-dependent changes in ionization can also cause 
bias unless corrected for. 
 
In LC-MS, GPLs are typically first quantified using MS scanning. Identification is then carried out 
in a second chromatographic run using MS/MS [137]. Alternatively, data-dependent acquisition 
on modern high-resolution instruments capable of MSn [138]  or  MSE [139, 140] allow for 
simultaneous quantification and identification of the GPL molecules in a single run.    
 
A drawback of LC-MS analysis of GPLs has been that a rather long time (often more than an 
hour) is needed for the LC separation. However, the recent introduction of UPLC equipment has 
reduced the time of separation to 10 min or less, thus making the acquisition time comparable 
to that required the DI-MS based shotgun analysis.  
 
 
2.2.2.5. Lipid imaging by MS 
 
With modified MS instruments it is possible to image the distribution of numerous lipid species 
in cells or tissues. Several different ionization methods have been explored in lipid imaging, 
including secondary ion MS (SIMS), MALDI and desorption ESI [141-143]. SIMS has the best 
resolution (<50 nm) and has been utilized to investigate the transport of [13C]-labeled oleate in 
an adipocyte [144]. Unfortunately, this method effectively fragments GPLs and thus imaging 
intact GPLs is currently not feasible [142, 144, 145]. However, cholesterol can be imaged with 
SIMS [145]. MALDI-based MS imaging does not allows imaging of subcellular compartments yet, 
but is readily applicable for imaging of GPLs and other lipids in tissue slices [143]. The 
distribution of lipids in brain and kidney as well as in an entire mouse has been studied by 
MALDI-imaging MS [143]. However, as with MALDI-MS in general, these data are biased due to 
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unequal ionization of the different lipid classes due to ion suppression by the matrix compound. 
Also Na+ and K+  adducts of the GPLs often interfere with data interpretation [143].  
 
2.2.2.6 Quantification of GPLs by ESI-MS 
Quantitative MS is best carried out using a stable isotope-labeled standard for each analyte 
[79]. This, however, is not feasible in global lipidomics since such standards are not available for 
each of the hundreds of different GPL species present in a typical mammalian cell. 
Consequently, accurate quantification of GPLs by ESI-MS is not straight-forward and several 
issues need to be considered. Typically, the intensity of ions deriving from any GPL species is 
not directly proportional to the concentration of that species. Several factors, such as the chain 
length and unsaturation of the acyl substituents and particularly the head group affect the 
instrument response [120]. In tandem MS, also the collision energy has a marked effect on the 
instrument response, [129, 146] and need to be accounted for. For accurate quantification of 
lipids by MS, it is essential to use internal standards for which the instrument response is similar 
to that of the analytes. For best accuracy, several standards for each lipid class should be 
included [120, 133]. According to some reports, phospholipid acyl chain length or unsaturation 
has no effect on the ionisation efficiency at low total lipid concentrations and, therefore, 
inclusion of a single  standard for each lipid class would be adequate, provided that the sample 
concentration is low [126, 146, 147]. This, however, limits the number of species that can be 
reliably quantified. 
 
Most of the elements have more than one stable isotope which differ in mass due to the 
presence of different number of neutrons. In particular, the abundance of the [13C] is fairly high 
(1% of carbon isotopes) and thus the MS spectra of all organic compounds display multiple, 
major isotope peaks [148]. Therefore, it is necessary to correct the so-called [13C] isotope 
effect, which varies with the number of carbon atoms present in the molecule [148]. 
Furthermore, many species within a lipid class are separated by only two mass units (one 
double bond), which leads to significant overlap of their isotopic patterns. For accurate 
quantification this overlap needs to be corrected for [148].  
 
 
2.3. ANALYSIS OF GLYCEROPHOSPHOLIPID METABOLISM 
 
 
Measuring of steady-state concentration of GPL in cells or tissues generally offers little 
information regarding their metabolism or its regulation (homeostasis). What are required are 
means to monitor time-dependent changes in the concentrations of GPLs and their 
metabolites. To achieve this, the investigator must use some kind of label and possess means to 
detect the label. Commonly used labels include radioisotopes, stable heavy isotopes and 
fluorescent tags. The benefits and drawbacks of each of these are briefly discussed next.   
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2.3.1. RADIOLABELING 
 
Studies of Chaikoff and co-workers in the late 1930’s [149-151] established radiolabeling as a 
powerful tool to investigate GPL metabolism. Since radioisotopes differ from normal atoms only 
in the number of neutrons present in their nuclei, compounds labeled with such isotopes are 
considered chemically identical to endogenous ones and thus radiolabeled GPLs are thought to 
faithfully report on the metabolism of the unlabeled molecules. However, the so-called isotope 
effect can cause deviating behavior in some cases. Radiolabeled compounds allowed Eugene 
Kennedy and co-workers to elucidate the biosynthetic pathways of GPLs [152-159] and has 
since been a key tool to investigate GPL metabolism, probably because their use is relatively 
straight-forward and does not require expensive equipment.  
 
The most commonly used radioisotopes [3H], [14C] and [32P] are used to label GPL precursors, 
which are then incubated with cells and become incorporated to GPLs and their metabolites. 
Typically head group precursors, such as choline, ethanolamine, or serine labeled with one of 
the isotopes is used to study GPL synthesis and turnover. Metabolism of the DAG-moiety of 
GPLs can be studied by radiolabeled glycerol, acetate or fatty acids.  
 
The labeled lipids (and/or their metabolites) are separated usually by TLC (or HPLC) and 
detected by autoradiography [160], liquid scintillation counting [161] or a phosphorimager 
[162]. The latter two methods provide quantitative information on the radioactivity of the 
separated compounds.   
 
The main benefit of radiolabeling is the sensitivity of detection [161], which allows one to use 
short labeling times. However, it should be noted that the limiting factor in metabolic studies is 
not the detection of radioactivity, but rather the determination of the chemical amount of the 
unlabeled species. This is because determination of the specific activity (i.e. units of 
radioactivity per mole of compound) is often required for meaningful interpretation of 
metabolic data. Although it is possible to label the cellular GPLs to an equal degree using long-
term (>48 h) incubation with [32P] [163], thus circumventing the need to determine their 
contents chemically, this approach has not gained popularity due to the short half-life of [32P] 
and particularly the safety issues of the high energy ?-radiation emitted by this radioisotope.  
 
Radiolabeling is particularly problematic when studying the metabolism of GPL molecular 
species, since one has to separate the species by reverse-phase HPLC, collect fractions and 
determine their radioactivity and phosphate content, which is laborious and insensitive. An on-
line radioactivity detector simplifies the process somewhat  [164] [39], but dos no eliminate the 
sensitivity problem. An additional complication is that the radiolabeled precursors are often 
metabolized to various compounds which can then incorporate to GPLs via other routes. For 
example, while radiolabeled serine mainly incorporates to the head group of PS, also other 
parts of the PS molecule become eventually labeled due to metabolism of serine to acetate, 
formate and glycine, which are incorporated to the glycerol and fatty acid moieties of GPLs via 
multiple pathways [165, 166]. Tedious control experiments (including phospholipase mediated 
hydrolysis) are necessary to account for such “false” labeling. There are innumerable studies 
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using radiolabeled compounds to study GPL metabolism, but their review is outside the scope 
of this thesis. 
 
 
2.3.2. FLUORESCENT LIPIDS  
 
Fluorescent tags can be used to monitor GPL metabolism, but have found limited use for two 
main reasons. First, the fluorescent tag is bulky and can thus severely bias the data. There is no 
simple way to account for such deviating behavior. The other problem is that the fluorescent 
tag, such as nitrobenzoxadiazole (NBD), dipyrromethene difluoride (BODIPY) typically attached 
to an acyl chain, increases the polarity of the parent molecule to such a degree that they are 
rapidly degraded by (unknown) housekeeping phospholipases [167-171].  Pyrene is 
hydrophobic and thus GPLs with a pyrene-labeled acyl chain are not rapidly degraded [172, 
173] and are metabolized similarly to their endogenous counterparts. For instance, a pyrene-PA 
was converted into diacylglycerol, triacylglycerol and PC and a pyrene-PS was decarboxylated 
into PE [173]. Also, pyrene-labeled fatty acids were readily incorporated  to GPLs of BHK21 cells 
[174]. Nevertheless, the pyrene moiety can certainly lead to deviating metabolic behavior as 
indicated by the fact that phospholipases can be very sensitive to the structure of the GPL acyl 
chains (see 5.3 and 5.4). GPLs with an acyl chain with several conjugated double bonds in the 
acyl chain (“polyene-lipids”) have been suggested to behave very similarly to natural ones 
[175], but this is uncertain as these derivatives have been employed only in few studies.  
 
 
2.3.3. STABLE ISOTOPE-LABELED PRECURSORS  
    
The most recent advancement in the analysis of GPL metabolism has been the utilization of 
stable heavy isotope labels, mainly [2H] (deuterium, D), [13C], [15N] or [18O]. Glycerol, fatty acids 
and head group precursors labeled with a stable isotope are commercially available at 
affordable prices, thus making stable isotope -labeling of phospholipids feasible. With tandem-
MS both labeled and unlabeled GPLs can be determined in parallel by adjusting a single 
parameter, e.g. the product ion mass [176, 177] or the neutral loss (Figure 11). Hence, pre-
existing and newly synthesized GPLs can be readily distinguished and quantified [178]. 
Furthermore, MS allows one to establish in which part of the molecule the label is located. Thus 
labeling of a “wrong” part of the molecule due to metabolism of the precursor via alternative 
pathways does not bias data interpretation, unlike when radiolabeled precursors are used. 
Most notably, however, stable isotope labeling allows facile tracing the metabolism of 
individual GPL-species, which is hard to achieve with the radiolabeling approach. Yet another 
advantage of stable isotope-labeling is that it is possible to perform lipid metabolic studies in 
human subjects as no obvious health issues are involved. 
 
The first studies on GPL metabolism with stable isotope -labeling typically employed GC-MS 
analysis. For example, incorporation of [18O] from H2
18O to the acyl carbonyl of GPLs was used 
to investigate acyl chain remodeling of GPLs in rat hepatocytes [179] and mouse macrophages 
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[180]. Analysis of [13C]-acetate incorporation to fatty acids by GC-MS and thermospray-LC-MS 
was utilized to show that de novo hepatic lipogenesis is a quantitatively minor pathway in man 
[181]. PC and DAG turnover in HL60 cells was investigated by incubating cells with [13C]-
palmitate, followed by GC-MS analysis [182].  
 
Considering the simplicity of studying stable isotope labeling of GPLs by ESI-MS/MS, this 
method has been adopted in surprisingly few studies. The first ESI-MS-based study on GPL 
metabolism utilized metabolic labeling with deuteriated choline and ethanolamine combined 
with specific MS/MS scans to demonstrate that the two pathways for PC synthesis (cf. Figure 1) 
produce different molecular species in rat hepatocytes [176]. A similar approach was adopted 
to study the substrate specificities of the enzymes of the respective PC-synthesis pathways in 
yeast [43, 183, 184]. The substrate specificity of human PC synthesis was investigated by 
MS/MS detection of labeled PC formed in CHO cells (over)expressing human CEPT [185]. PI and 
PC turnover and acyl chain remodeling in a variety of mammalian cell lines and tissues was 
investigated by pulse-chase labeling with deuteriated choline and inositol followed by ESI-
MS/MS detection of labeled and unlabeled PI and PC species [48, 177, 186]. Binder et al. 
investigated the effect of cholesterol or low density lipoprotein-loading on PC, PE and PS 
synthesis in human fibroblasts using deuteriated head group precursors [42]. They showed PC 
synthesis was enhanced and synthesis of PE down-regulated in cells loaded with cholesterol, 
free fatty acid or lipoproteins. Loading also modified the molecular species profiles of the cells. 
Transport of PS from the endoplasmic reticulum to mitochondria in BHK cells was investigated 
using labeling with deuteriated serine and detection of labeled PS and PE species by ESI-MS/MS 
[187]. Kainu et al. used exogenous deuterium-labeled PS species to study transport of PS from 
the plasma membrane to mitochondria [188]. As noted above, stable isotopes can be used to 
probe lipid metabolism also in humans because of their (presumed) safety. For example, D9-
choline was used to investigate lung surfactant PC synthesis and turnover in human volunteers 
[189].     
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FIGURE 11: ESI-MS/MS allows for simple detection of unlabeled and D4-labeled PE species. HeLa cells were 
incubated with 100 ?g/ml D4-ethanolamine for 8 hours, the lipids were then extracted and the extract was infused 
to an ESI-MS instrument. Unlabeled and D4-labeled PE-species were detected by using head group-specific neutral 
loss scanning. (A) NL141-spectrum corresponding to unlabeled PE. (B) NL145-spectra corresponding to D4-labeled 
PE. (C) Overlay of the NL141 and NL145 spectra. Note that the D4-labeled PE species are 4 mass units heavier than 
the corresponding unlabeled ones. Unpublished data.  
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3. AIMS OF THE PRESENT STUDY 
 
The main goals of this study were to develop tools to investigate glycerophospholipid 
metabolism in mammalian cells. More specific aims were as follows: 
 
- To develop an automated method for the analysis of phospholipid compositions of 
complex biological samples 
- To test whether imbalance in brain lipid metabolism could contribute to the 
pathophysiology of progressive epilepsy with mental retardation  
- To develop means to probe the glycerophospholipid acyl chain remodeling process in 
living cells  
- To investigate the factors contributing to the substrate specificity of A-type 
phospholipases, which are presumably key players in maintenance of cellular 
glycerophospholipid homeostasis  
- To draw together the current knowledge of the processes contributing to the 
maintenance of mammalian glycerophospholipid homeostasis to identify “blind spots” 
of current glycerophospholipid research  
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4. EXPERIMENTAL PROCEDURES 
 
The experimental procedures used in the original articles and unpublished data are summarized 
in the table below.  Either the reference or the number of the original publication in which the 
method has been described is indicated. 
 
Method Reference 
Cell culture of CHO, BHK and HeLa cells    I,III 
Labeling of cells with D4-ethanolamine III 
Labeling of cells with exogenous deuterium-labeled phospholipids III 
Parameters used in mass spectrometry I, III, IV 
Liquid chromatography-mass spectrometry I,II 
Synthesis of MS standards I,III,IV 
Synthesis of deuterium-labeled PE and PS III 
Synthesis of deuterium-labeled PCs IV 
Synthesis of Cn/16:0-PC ands 16:0/Cn-PCs IV 
Lipid purification by HLPC [88] 
PLA specificity assay    
 
IV 
Lipid extraction [190] 
Protein determination [191] 
Phosphorus determination [192] 
Cholesterol determination [193] 
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5. RESULTS AND DISCUSSION 
 
 
The results of this thesis are presented in the four original research articles (I-IV) and one 
review (V).  
 
The first paper (I) describes an automated method for analysis of complex lipidomes based on 
liquid chromatography-mass spectrometry. Application of the automated method is presented 
in the following paper (II), which reports alterations in cerebral lipid composition of patients 
with progressive epilepsy with mental retardation, EPMR.  
 
In the third paper (III), a novel approach to study GPL metabolism in cultured cells was 
developed and applied to investigate acyl chain remodeling of PE and PS  
 
The fourth paper (IV) provides novel information on the mechanisms underlying the substrate 
specificity of secretory A-type phospholipases 
     
In the fifth publication (V) the mechanisms of GPL-homeostasis in mammalian cells are 
reviewed and discussed and additional theoretical considerations presented.  
 
 
5.1. AUTOMATED QUANTITATIVE ANALYSIS OF COMPLEX LIPIDOMES (I) 
 
At the time this work was initiated, it was becoming apparent that ESI-MS was becoming the 
method of choice in lipid analysis or “lipidomics”. However, the data analysis methods were not 
up to par with the vast amounts of data produced by MS, but was rate-limiting due to the 
extensive manual work required. Consequently, we decided to develop an automated method 
that allows unattended identification and quantification of lipid molecular species of all the 
major lipid classes from a two-dimensional chromatographic/mass spectrometric data set 
(Figure 12). Such an automatic method was considered a necessity for any large-scale routine 
lipidomics application. 
 
We chose to carry out the on-line chromatographic separations isocratically on a diol-modified 
silica column using hexane/isopropanol/water-based mobile phase with formic  
acid and triethylamine as additives. This system allowed the detection of all major 
glycerophospholipid classes and many sphingolipid classes, either as [M ? H]- or [M + HCOO]- 
ions (Fig. 12A,B). In addition, it provided a nearly symmetric peaks (Fig. 12C) and a good 
retention time stability (±2%), which are very useful for a computerized data analysis.  
 
The computerized data analysis software is a key novel feature of this study and consists of 
three main tasks: (i) finding and fitting of the relevant chromatographic signals, (ii) assignment 
of the signals to specific lipid species, and (iii) quantification of those species. These issues are 
now discussed in more detail. 
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The first task is to extract all relevant signals from the data. This is achieved by sequentially 
fitting a signal model (a mass-dependent generic isotope pattern) to the highest peak, 
subtracting the fit from the data, and repeating the process until all significant signals are 
detected. This is probably the first study to fit LC?MS data in its native two-dimensional format. 
Such fitting makes the deconvolution and integration of complex signal patterns more accurate 
than if only spectral data is used [136, 194]. This is because even when signals of different lipid 
species overlap in the mass dimension, they are usually (at least partially) separated in time 
(Fig. 12C). The quality of fitting obtained was very good (Fig 12E,F).  
 
The second task the program carries out is the assignment of the signals (peaks) to lipid species. 
The assignment relies on the identification of at least two lipid species (reference compounds) 
in a reference chromatogram by the operator. The algorithm first finds the reference 
compounds based on (i) their given relative retention times within the respective class and (ii) 
the relative retention time order of lipid classes. In the next step, all signals that have the 
correct m/z and lie in the predicted retention time window are assigned to lipid species found 
in the database. 
 
 In the MS chromatogram shown in Fig. 12A, the automatic method detected 136 lipid species 
belonging to 11 different lipid classes (color coded in Fig. 12B). Among the 136 automatically 
assigned signals only 3 were found incorrect, while 2 signals were assigned to 2 alternative 
species one of which was the correct one. Tests of reproducibility showed that all of the species 
representing >3 pmol were assigned correctly at least 20 times out of 22 (I, Fig S3). Even many 
less abundant species (>1 pmol) were reliably found (?19/22). Statistical analysis indicated that 
signals exceeding 10000 counts, i.e. ~2?4 pmol, were correctly assigned in >95% of the 
replicates (I, Fig. S5).  
 
The third and final task of the software is to quantify the found (assigned) lipid species. For 
accurate quantification of GPLs by MS, it is essential to use internal standards for which the 
instrument response is as similar as possible to that of the analytes [120]. Previous studies had 
indicated that the response factor is very sensitive to variations in head group structure as well 
as acyl chain length and unsaturation, particularly at higher total lipid concentrations [120]. 
Thus, for best accuracy, several standards for each lipid class should be included. To avoid the 
complication of obtaining several standards for each lipid class, some investigators have chosen 
to operate at low total lipid concentration. While relatively accurate results could be obtained 
this way, we prefer to include several internal standards per lipid class since (i) a greater 
number of minor lipid species can be analyzed when using higher total lipid concentrations and 
(ii) and there is no need to strictly control the total lipid concentration. Yet another important 
benefit of several standards for this method is that they assist in the assignment of the 
analytes. The software first adjusts the signal according to the compound-specific isotope 
pattern by dividing the area of the first isotope by its theoretical relative abundance. Then an 
instrument response versus m/z -function is derived based on the intensities obtained for the 
internal standards [119, 120] and finally, this function is used to calculate the amounts of the 
analytes.  
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FIGURE 12.Two-dimensional display of LC?MS data obtained for mouse brain lipid extract. (a) Negative ion mode 2-
D LC?MS data.  (b) Assignment of the signals shown in panel a. The lipid classes from left to right are as follows: 
blue at ~7 min, PA; black, Galactosylceramide; gray, ?-hydroxygalactosylceramide; violet, PE plasmalogens, green 
at ~12 min, PE; brown, PC;  blue at ~25 min, SM; dark yellow, sulfatides; gray at ~28 min, ?-hydroxysulfatides; 
green at ~27 min, PS and blue at ~38 min, PI. (c) Enlarged view of the region indicated by the rectangle in panel a. 
(d) A 3D view of the data in panel c showing the projections in the time (left wall) and mass (right wall) directions. 
(e) Recorded (blue line) and fitted (red line) ion chromatogram for m/z 774.2 (PE alkenyl-40:6) at 7?14 min. (f) 
Recorded (blue line) and fitted (red line) mass spectra at 10.5 min corresponding to the area shown in panel a. 
Reprinted with permission from (Hermansson et al. (2005), Anal Chem 77, 2166-75). Copyright (2005) American 
Chemical society.   
 
The results obtained with mixtures of synthetic standards as well as with biological samples 
indicated that the automated method was both accurate and reproducible (I, Fig. 2). With the 
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MS instrument used, the detection limit was 2-4 pmol and the linear range covered more than 
3 orders of magnitude (I, Fig. 3).  
 
The automated method does not allow one to quantify isobaric species with different fatty acid 
residues or positional isomers. However, the data (I, Fig. 4) indicate that this would be possible, 
since partial in-source fragmentation of the GPLs produced abundant fatty acyl carboxylate 
anions and lyso-GPL fragments “coeluting” with the parent lipid, thus allowing identification of 
the fatty acid residues and their sn positions.  
 
In conclusion, using the computerized method described in publication I, more than 130 polar 
lipid species could be automatically quantified from biological samples with good accuracy and 
reproducibility. The method was found to be generally applicable as samples of very different 
compositions could be analyzed reliably. Up to 35 samples could be analyzed in a day. Thus, this 
method would be useful particularly in studies requiring analyses of large sample sets. The main 
drawback of the method in its present form is that the software is command-line driven and 
thus requires some expertise in computing. 
 
 
5.2. CHARACTERIZATION OF BRAIN LIPIDOMES OF EPMR-PATIENTS (II)  
 
Progressive epilepsy with mental retardation (EPMR) is an inherited neurodegenerative 
disorder caused by mutations in the CLN8 gene [195]. CLN8 encodes a transmembrane protein 
that localizes to the endoplasmic reticulum. The function of CLN8 is unknown, but it is linked to 
a large eukaryotic protein family of TLC domain homologues with postulated functions in lipid 
synthesis, transport or sensing [196].  
 
To investigate whether CLN8-deficiency caused alterations in the lipid compositions of the brain 
of EPMR-patients we applied the quantitative lipidomics approach described in publication I to 
analyze GPL, neutral sphingolipid and sulfatide compositions in cerebral samples of two EPMR 
patients with a progressive and advanced state of the disease as well as age-matched controls. 
The progressive state brain had reduced levels of ceramide, galactosyl- and lactosylceramide, 
sulfatide (II, Fig. 1) and cholesterol (II, see text), as well as a decreased levels of long fatty acyl 
chain -containing species (II, Figs. 3-6). In GPLs, an increase in species containing 
polyunsaturated acyl chains was detected, especially in PS and PE (II, Fig. 2). By contrast, 
saturated and monounsaturated species were overrepresented in PS, PE and PI in the advanced 
state brain (II,  Figs.  2  & S1). These changes in brain sphingo- and phospholipid profiles could 
compromise membrane structure, vesicular trafficking or neurotransmission or could increase 
lipid peroxidation, and may thus contribute to the progression of EPMR. Consistently, a recent 
publication indicates that mice lacking Cln8 have reduced levels of galactolipids and significant 
myelin defects in the brain [197]. 
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5.3. AMINOPHOSPHOLIPID ACYL CHAIN REMODELING (III) 
 
To investigate the mechanisms of GPL acyl chain remodeling we devised a novel approach 
which involves 1) synthesis of GPL with a deuterium-labeled head group, 2) introduction of a 
labeled GPL from donor vesicles to cells using of methyl-?-cyclodextrin as a carrier and 3) ESI-
MS/MS analysis of its metabolism. The key advantage of using intact exogenous GPLs rather 
than labeled precursors is that, initially, only a single labeled species is present in the cell. Thus 
the remodeling pathways and kinetics as well as turnover of the individual lipid species could be 
determined in a far more detailed manner than had been possible previously. Using this novel 
approach we conducted an extensive study involving >30 different exogenous PE and PS species 
to study GPL acyl chain remodeling in BHK and HeLa cells.   
 
One of the key findings of this study was that all PE and PS species were remodeled in BHK and 
HeLa cells, but the extent of remodeling, as well as the turnover rates, varied markedly 
between species. Intriguingly, unnatural PE and PS-species (those not present endogenously), 
were remodeled rapidly at both sn1 and sn2 position, eventually to molecular species similar to 
the endogenous ones (III, Figs 1,3,4). For example, unnatural 14:1/14:1-PE and PS species were 
rapidly remodeled to natural species such as 18:1/18:1-PE and 18:0/18:1-PS, respectively (III, 
Fig. 1&4). In contrast, remodeling of exogenous species identical or similar to major 
endogenous ones was limited and much slower (III, Fig. 1&4).  
 
Because PLAs catalyze the first, committed step of the remodeling process, these data mean 
that those PLAs recognize minor structural differences in the GPL substrate. Both PLA1 and PLA2 
activities must be involved, since most exogenous PE and PS species were remodeled both at 
sn1 and sn2 positions, in agreement with earlier studies [40, 179]. A novel finding is that both 
the kinetics and the sequence of the sn1 vs. sn2 remodeling are very sensitive to the 
phospholipid acyl chain and head group structure. The remarkable selectivity of the PLAs is 
indicated by that very different remodeling pathways and kinetics were observed for PE and PS 
positional isomers, i.e. species containing identical fatty acids (e.g., myristate and oleate) but in 
reversed sn positions. While 14:0/18:1-PE was slowly remodeled at the sn1 position to yield 
18:1/18:1-PE (Fig. 13), its positional isomer 18:1/14:0-PE was very rapidly remodeled at the sn2 
position, yielding a multitude of different species (Fig. 13). These data show that acyl chain 
remodeling and selective turnover play an important role in GPL homeostasis in mammalian 
cells. Interestingly, PE species containing saturated acyl chains at sn2 position were 
exceptionally good substrates for the remodeling PLAs, as such species were very rapidly 
remodeled (Fig. 13 & III, Fig 3). While the reason for this is currently unclear, this is consistent 
with the fact that mammalian PE does not contain saturated acyl chains at sn2 position [198, 
199]. 
 
 
 
 32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 13. Remodeling of exogenous 14:0/18:1-D4PE 18:1/14:0-D4PE species in BHK21 cells. A  D4-labeled PE 
species was introduced into cells and then chased for up to 24 h as outlined in Paper III. After lipid extraction, ESI-
MS/MS spectra were obtained using neural loss of 145 (labeled species)  or  141  (unlabeled species, endo). The 
duration of chase is indicated on the right. The precursors are underlined in the uppermost panels. The spectra 
have been normalized to the highest peak, and the x-axis scales have been adjusted to facilitate comparison of the 
labeled and unlabeled species. Unpublished data.    
 
 
Earlier studies have implicated several PLA2 enzymes in the remodeling process [32, 34, 200, 
201]. Our studies with pharmacological inhibitors indicated that a cPLA2, iPLA2? and iPLA2? are 
involved in the remodeling PE and PS  (III, Fig. 5&6).  However, also other, unidentified, PLAs 
seem to participate in this process. Consistently with our data, existence of head group-specific 
PLAs in mammalian cells have been obtained previously [24, 202]. However, results obtained 
with pharmacological inhibitors should be considered only tentative since they are not fully 
specific for a particular PLA [203-206]. RNA interference [207] is more specific and will be used 
in our future studies.   
 
To investigate the enzymes involved in reacylation of lysoPS and -PE we studied the effect of 
Triacsin C, an inhibitor of acyl-CoA synthases [208]. Triacsin C inhibited remodeling of all PS, but 
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none of the PE species tested (III, Fig 5&6), thus suggesting that acyl-CoA-dependent 
acyltransferases are involved in remodeling of PS. Consistently, previous studies have shown 
that reacylation of the sn2 position of lyso-PS occurs by acyl-CoA-dependent acyltransferases 
[209, 210]. Notably, Triacsin C did not inhibit the remodeling of any PE species and thus 
reacylation of lysoPE is probably catalyzed by transacylases as also indicated by previous studies 
[17, 211].   
 
The enzymes implicated in PL remodeling have been localized to several intracellular locations 
including the ER, the Golgi, mitochondria, nucleus and peroxisomes [30]. Thus it is an intriguing 
possibility that the organelles harbor a unique set of remodeling enzymes, which could 
contribute to their specific lipid compositions [3]. Such organelle -specific remodeling has been 
found for endonuclear PI and PC [177].  
 
Previously several other methods, e.g. phospholipid transfer protein-mediated transport [212, 
213] and vesicle fusion via virus receptors have been used to introduce lipids to cells [214], but 
these methods have various complications and have been rarely used. LysoGPLs are readily 
taken up by cells and reacylated therein [215]. They allow one to introduce phospholipids with 
a particular (labeled) head group to cells. However, the reacylation process is not fully selective 
regarding the acyl chain added to the lysolipid and therefore this approach does not allow 
introduction of a specific molecular species to cells. This is feasible by using methyl-?-
cyclodextrin to carry intact exogenous GPLs from vesicles to cells as done in the present study. 
This method is very efficient, simple and gentle to cells [188] and will thus be helpful in future 
studies on cellular GPL metabolism. 
 
 
5.4. PHOSPHOLIPASE SUBSTRATE SPECIFICITY (IV) 
 
As indicated above, A-type phospholipases (PLAs) are key players in GPL homeostasis. 
Therefore, it is important to establish the factors determining their specificity. In the past, 
different approaches have been adopted to investigate the substrate specificity of these 
enzymes. Initially, vesicles consisting of a single phospholipid species were used the 
macrosubstrate. This, however, is not a good approach, since the rate of hydrolysis can reflects 
more the affinity of the PLA for the vesicles (which varies depending on phospholipid used), 
rather than the substrate specificity proper [216]. More reliable information can obtained by 
comparing hydrolysis of two lipids labeled with different radioisotopes and present 
simultaneously in the macrosubstrate [216]. However, this approach is not practical when a 
large number of species are to be studied. Also liposomes made of a mixture natural lipids have 
been used as the macrosubstrate [217, 218], but only limited information on the effects on acyl 
chain length, unsaturation and sn position on PLA activity can be obtained.   
 
Mass spectrometry provides a powerful means to analyze PLA specificity by allowing one to 
study the hydrolysis of a multitude of species in parallel, as shown in a recent study where the 
hydrolysis of the phospholipids present in lipoprotein particles by secretory PLA was 
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investigated  [219, 220]. Here, we used an analogous approach but used micelles and small and 
large unilamellar vesicles as the macrosubstrate.  
 
The macrosubstrate contained mixture of PC species and 5 mol% of phosphatidylglycerol to 
provide negative charge increasing the affinity of the enzymes for the macrosubstrate. In 
addition, a sphingomyelin species was included as a nonhydrolyzable internal standard. Three 
different mixtures of PC species were studied. One consisted of 27 PC species with varying acyl 
chain length (13 - 22 carbons) and the number of double bonds (0 - 12). The other mixture 
consisted of 18 saturated PC species with a 16:0 sn1 chain and a sn2 chain of variable number 
of carbons (16:0/Cn-PCs; n = 6-24), while the third one (Cn/16:0-PCs) consisted of the positional 
isomers of those in the second mixture. The Cn/16:0-PC species contained a D9-labeled choline 
head group, while the 16:0/Cn-PC species were unlabeled. Both sets were present together in 
same vesicles or micelles, thus allowing us to study the hydrolysis of the positional isomers 
under identical conditions. After addition of PLA, aliquots were removed at intervals from the 
reaction mixture and concentrations of the individual PC species relative to the non-
hydrolyzable SM-standard were determined by MS. (IV, Fig. 1A) shows exemplary data before 
and after incubation with bee PLA2. Major differences in the rate of hydrolysis between PC 
species are obvious (IV, Fig. 1B).   
 
Figure (IV, Fig. 2) shows the relative rates of hydrolysis of PC with varying acyl chain length and 
unsaturation by the three PLAs in octylglucoside micelles. Each enzyme responded differently 
to the number of acyl chain double bond and their position, presumably due differences in their 
substrate binding sites (IV, Fig. 2). Hydrolysis by bee PLA2 increased markedly with increasing 
acyl chain unsaturation and the arachidonic acid -containing species were especially good 
substrates for this enzyme. The cobra PLA2 preferred species with a 22:6 or 18:3 chain, while 
the porcine PLA2 favored short diunsaturated species as well as the 16:0/18:2 and di-18:3 
species. These data suggest that the acyl-binding sites of the three PLA2s differ significantly, 
which is to be expected based on the 3-D structures of these proteins [221, 222]. Experiments 
with the positional isomers indicated that the length of the sn2 chain was more critical than 
that of the sn1 chain (Figure 14). Peaking of the activity when the length of the sn2 chain is 9-10 
carbons indicates that this equals the dimension of the sn2 chain binding cavity these enzymes, 
in agreement with previous crystallographic data [222, 223].  
 35
 
 
 
FIGURE 14. PLA2-mediated hydrolysis of 16:0/Cn-PC and 
Cn/16:0-PC species in octylglucoside micelles vs. the length of 
the variable acyl chain. D9-16:0/Cn-PCs, Cn/16:0-PCs, POPG, and 
17:0-SM were dispersed in 30 mm octylglucoside and 
incubated with bee PLA2 (A), cobra PLA2 (B), or porcine PLA2 (C) 
at 37 °C. Relative rates of hydrolysis were determined as 
described in paper IV and are plotted against the number of 
acyl chain carbons in the variable chain for both isomeric sets. 
(D) The isomer preference was obtained from data in panels 
A–C by pairwise division of the rate of 16:0/Cn-PC hydrolysis by 
that  of  Cn/16:0-PC. The dotted line at y = 1.0 indicates the 
absence of isomer preference. The data shown are mean ± S.D. 
of three independent experiments. Reprinted with permission 
from original publication IV.   
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Intriguingly, the specificity profiles obtained with vesicles for the 3 PLA2s differed markedly 
from those obtained with micelles (IV, Fig. 3). In particular, the difference between the slowest 
vs. fastest rate was far more pronounced (up to 100-fold) than in micelles (10-fold). The rate of 
hydrolysis of both saturated and diunsaturated PC species decreased strongly and 
monotonously with increasing acyl chain length. In addition, the hydrolysis increased with 
increasing degree of unsaturation (IV, Fig. 3). 
  
Strikingly, no discrimination between positional isomers was observed with vesicles as the 
macrosubstrate, and hydrolysis decreased far more with increasing chain length than with 
micelles (IV, Fig. 5). This very strong dependency on the chain length as well as the lack of 
discrimination between positional isomers strongly suggests that the efflux of the phospholipid 
substrate is a key factor in PLA specificity acting on membranes. Supporting this, acyl chain 
structure influenced hydrolysis and spontaneous intervesicle transfer (which correlates with 
lipid efflux propensity) in an analogous manner (Figure 15). Studies with cross-linkable 
phospholipids support the notion that efflux propensity is a key factor regulating the hydrolysis 
of membrane bound substrates by secretory PLA2s [224, 225]. 
 
We conclude that substrate efflux propensity plays a more important role in the specificity of 
secretory PLAs than commonly thought, and speculate that it could regulate the hydrolysis on 
GPLs by homeostatic phospholipases as well. 
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FIGURE 15. Spontaneous intervesicle transfer of PC species correlates with their rate of hydrolysis. (A) Relative 
transfer rates for the PC species were determined as described in publication IV and are plotted on a logarithmic 
scale against the total acyl chain carbons for species with different number of double bonds in the acyl chains. The 
lines are linear fits to data. The dashed lines are extrapolations. (B) Semilogarithmic plot of the rate of hydrolysis by 
bee PLA2 of the species in PC-mix27 versus the total number of acyl chain carbons. Note that the y-scales are very 
different in A and B. Reprinted with permission from original publication IV. 
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6. CONCLUSIONS AND PERSPECTIVES  
Methods for analysis of cellular glycerophospholipid compositions and metabolism were 
developed and the processes contributing to maintenance of cellular glycerophospholipid 
homeostasis reviewed. I will briefly sum the key conclusions and indicate future directions that 
may be taken based on these studies.    
1) The developed automated liquid chromatography-mass spectrometric method was found 
effective and reliable for analysis of complex lipidomes from cells and tissues. Further 
development of the software to suit modern high-resolution mass spectrometers as well as 
inclusion of a user-friendly graphical interface would improve the usability and adaptability 
of the method.  
 
2) Mass-spectrometric lipid profiling of cerebral samples from patients with progressive 
epilepsy with mental retardation (EPMR) revealed major progressive changes in neural 
lipids. Thus, impairment of brain lipid metabolism could contribute to the progression of the 
disease. Further studies on the function of the CLN8-protein are needed to establish 
whether impaired lipid metabolism is a primary or a secondary event in pathophysiology of 
EPMR.  
 
3) A novel approach to investigate GPL acyl chain remodeling in living cells was developed. We 
showed that the remodeling pathways and kinetics of GPL remodeling are highly dependent 
on the acyl chain composition as well as the polar head group of the GPL molecule. The 
remodeling process involves multiple distinct phospholipases targeting both sn1 and sn2 
positions and various acyltransferases and transacylases. The data obtained lays a basis for 
future studies to elucidate the specific enzymes involved in GPL remodeling, as will be 
detailed below.  
 
4) A mass-spectrometric high-throughput assay to probe phospholipase substrate specificity 
was developed. As a proof-of-the-principle we elucidated the specificities of three secretory 
A-type phospholipases and showed that their specificity depends mainly on the propensity 
of the phospholipid substrate to efflux from the membrane while interactions between the 
substrate and the catalytic site are secondary. We speculate that this could be the case with 
homeostatic (unidentified) intracellular phospholipases as well. Once identified and 
available as relatively pure preparates the assay described here can be utilized to determine 
the specificities of the homeostatic phospholipases to gain insight to their mode of action.   
 
5) Processes contributing to maintenance of glycerophospholipid homeostasis in mammalian 
cells, i.e. biosynthesis, degradation, acyl chain remodeling and intracellular transport, were 
reviewed. It was established that while the enzymes responsible for GPL biosynthesis are 
well elucidated, their regulation is still poorly understood, probably because many of them 
are transmembrane proteins, the purification and reconstitution of which is exceedingly 
difficult. Surprisingly little is known about GPL degradation and the enzymes involved 
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remain largely unknown despite the fact that over 50 different phospholipases have been 
characterized in mammals. Also, while it is established that synthesis and degradation are 
coordinately regulated, probably to prevent futile competition between these opposing 
processes, it is not understood how such regulation is accomplished. Finally, while 
intercellular GPL transport is essential for maintenance of the GPL compositions of 
organellar membranes, the mechanisms of this process are far from established. In 
conclusion, lipid scientists have plenty of work ahead.        
 
6) Introduction of exogenous heavy isotope-labeled phospholipids to cells combined with 
mass spectrometry employing class-specific scans is a powerful tool to study phospholipid 
metabolism. As indicated by chapter 5.3, explicit and highly detailed data on metabolism 
(e.g. remodeling and degradation) of a single GPL molecular species can be obtained by 
using this approach. Our subsequent studies indicated that the method is also very useful 
when studying intracellular transport of GPLs [188]. Furthermore, we showed that 
introduction of exogenous GPLs to cells using cyclodextrin as carrier enables extensive 
manipulation of the GPL composition of mammalian cells without compromising cell 
integrity or viability [188]. Such manipulation has not been possible previously. Thus, it can 
be envisioned that the approach, when combined e.g. with RNAi-based knock-down of 
various enzymes putatively involved in synthesis, degradation, remodeling and transport of 
GPLs, allows one to answer many of the open questions listed above.  
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